An international team, led by University of California, San Diego School of Medicine researchers, has been awarded a $6.5 million grant from the National Institutes of Health (NIH) to study the pharmacogenomics of a key mood-stabilizing drug used to treat bipolar disorder. The grant expands the NIH's Pharmacogenomics Research Network (PGRN), a long-term, multi-million dollar effort to investigate and fulfill the potential of personalized medicine. John R...
More...
More...